(No ratings)
Dr. Alexander J. Chou, MD is a pediatric oncologist in New York, NY specializing in pediatric oncology and general pediatrics. Dr. Alexander J. Chou, MD is affiliated with NewYork-Presbyterian and Pediatric Hematology/Oncology.
525 East 68th Street
New York, NY 10065
He is certified by the Pediatric Hematology-Oncology Pediatrics and has a state license in New York.
Board Certification: Pediatric Hematology-Oncology Pediatrics
Licensed In: New York
Dr. Alexander J. Chou, MD is associated with these hospitals and organizations:
Dr. Alexander J. Chou, MD appears to accept the following insurance providers: GHI, VNSNY CHOICE, Empire Blue Cross/Blue Shield, Health Insurance Plan of NY (HIP), Oxford Health Plans, Aetna - NYP, AETNA, Empire Blue Cross/Blue Shield Healthplus, United Healthcare, Health Insurance Plan of New York (HIP), Group Health Incorporated (GHI), Aetna, Empire BlueCross BlueShield, United Healthcare and Oxford Health Plans.
According to our sources, Dr. Alexander J. Chou, MD accepts the following insurance providers:
Dr. Alexander J. Chou, MD does not have any reviews yet, be the first to leave a review of Dr. Alexander J. Chou, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Alexander J. Chou, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Y-mAbs Therapeutics, Inc. |
$2,300
DANYELZA $2,300 |
---|---|
Pfizer Inc. |
$100
$100 |
Amgen Inc. |
$25
Blincyto $25 |
AbbVie Inc. |
$18
DALVANCE $18 |
Consulting Fee | $2,300 |
---|---|
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100 |
Food and Beverage | $43 |
Dr. Alexander J. Chou, MD has received 5 research payments totaling $47,500.
Dr. Alexander Chou is a physician who specializes in pediatric hematology/oncology and general pediatrics. He is professionally affiliated with NewYork-Presbyterian. He has a closed panel according to Yext.